NCT07242430 12-week Multi-vitamin/Mineral Supplementation on Peri-menopause Symptoms, Cognition, Sleep, and Psychological Well-being.
| NCT ID | NCT07242430 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northumbria University |
| Condition | Perimenopause |
| Study Type | INTERVENTIONAL |
| Enrollment | 58 participants |
| Start Date | 2026-04-07 |
| Primary Completion | 2026-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 58 participants in total. It began in 2026-04-07 with a primary completion date of 2026-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Perimenopause is a stage of transition into menopause that is marked by menopausal symptoms while menstruation is still taking place. Perimenopause symptoms include mood changes, anxiety, sleep disruptions, hot flushes, night sweats, fatigue, and cognitive challenges. The frequency and severity of these symptoms can seriously impair women's quality of life. Even if the public's awareness on menopause has increased, there are still a lot of unanswered questions. A connection between nutrition and menopause management has been proposed in earlier research. However, there is limited research in this field, and women frequently turn to social media for supplement recommendations in order to deal with menopause-related issues. Vitamins and minerals such as vitamin D and calcium are recommended by the European Menopause and Andropause Society and there is limited evidence to suggests that soy and herbals may have a beneficial effect on menopausal symptoms, but more research is needed. The aim of this study is to investigate the effects of 12-weeks multi-vitamin/mineral and herbal extract-containing supplement on menopause symptoms, memory and concentration, sleep, and psychological well-being.
Eligibility Criteria
Inclusion Criteria: * Self-assess as healthy * Report experiencing troublesome peri-menopause symptoms in the past 6 months but not post-menopausal (defined as 12 months with no periods) Exclusion Criteria: * Post-menopausal * Lactating, pregnant or seeking to become pregnant * Nut Allergy * Taken antidepressant/antianxiety medication or other medication with strong likelihood for effects on cognition or sleep in the past 6 months. * Habitual multi-vitamin/mineral supplementation (defined as more than 3 consecutive days or 4 days in total). Will be excluded unless washout for 1 month. * Menopause symptoms have been medically induced. * Receiving gender-affirming hormone therapy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07242430 clinical trial?
This trial is open to female participants only, aged 40 Years or older, up to 60 Years, studying Perimenopause. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07242430 currently recruiting?
Yes, NCT07242430 is actively recruiting participants. Contact the research team at crystal.haskell-ramsay@northumbria.ac.uk for enrollment information.
Where is the NCT07242430 trial being conducted?
This trial is being conducted at Newcastle upon Tyne, United Kingdom.
Who is sponsoring the NCT07242430 clinical trial?
NCT07242430 is sponsored by Northumbria University. The trial plans to enroll 58 participants.